Quantcast
France's HAS says Novavax and Janssen vaccines are good alternative - Metro US

France’s HAS says Novavax and Janssen vaccines are good alternative

FILE PHOTO: FILE PHOTO: Vials and medical syringe are seen in front of Novavax's logo in this illustration

PARIS (Reuters) – French health authority HAS said on Friday that Novavax’s Nuvaxovid and Janssen’s COVID-19 vaccine offered an efficient alternative for people hesitant about RNA-based vaccines or who cannot take these for medical reasons.

HAS said RNA-based vaccines remain the preferred option, but that the two other vaccines should also be part of France’s vaccination strategy.

(Reporting by Jean-Stephane Brosse, writing by GV De Clercq, Editing by Catherine Evans)

More from our Sister Sites